ImmuPharma plc IMM.L Stock
ImmuPharma plc Price Chart
ImmuPharma plc IMM.L Financial and Trading Overview
ImmuPharma plc stock price | 2.48 GBP |
Previous Close | 3.24 GBP |
Open | 3.78 GBP |
Bid | 3.01 GBP x 0 |
Ask | 3.49 GBP x 0 |
Day's Range | 3.1 - 3.78 GBP |
52 Week Range | 1.36 - 7.6 GBP |
Volume | 5.96K GBP |
Avg. Volume | 1.66M GBP |
Market Cap | 10.67M GBP |
Beta (5Y Monthly) | 1.435249 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 14, 2021 |
1y Target Est | N/A |
IMM.L Valuation Measures
Enterprise Value | 10.25M GBP |
Trailing P/E | N/A |
Forward P/E | -0.009144542 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 387.49997 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -3.521 |
Trading Information
ImmuPharma plc Stock Price History
Beta (5Y Monthly) | 1.435249 |
52-Week Change | -44.017% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7.6 GBP |
52 Week Low | 1.36 GBP |
50-Day Moving Average | 2.9 GBP |
200-Day Moving Average | 2.84 GBP |
IMM.L Share Statistics
Avg. Volume (3 month) | 1.66M GBP |
Avg. Daily Volume (10-Days) | 1.15M GBP |
Shares Outstanding | 333.4M |
Float | 261.12M |
Short Ratio | N/A |
% Held by Insiders | 54.31% |
% Held by Institutions | 19.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -37.96% |
Return on Equity (ttm) | -109.77% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -2911389 GBP |
Net Income Avi to Common (ttm) | -3807431 GBP |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 667.81K GBP |
Total Cash Per Share (mrq) | 0.002 GBP |
Total Debt (mrq) | 111 GBP |
Total Debt/Equity (mrq) | 0.004 GBP |
Current Ratio (mrq) | 1.612 |
Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2347065 GBP |
Levered Free Cash Flow (ttm) | -2738621 GBP |
Profile of ImmuPharma plc
Country | United Kingdom |
State | N/A |
City | London |
Address | 1 Bartholomew Close |
ZIP | EC1A 7BL |
Phone | 44 20 7206 2650 |
Website | https://www.immupharma.co.uk |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
Q&A For ImmuPharma plc Stock
What is a current IMM.L stock price?
ImmuPharma plc IMM.L stock price today per share is 2.48 GBP.
How to purchase ImmuPharma plc stock?
You can buy IMM.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmuPharma plc?
The stock symbol or ticker of ImmuPharma plc is IMM.L.
Which industry does the ImmuPharma plc company belong to?
The ImmuPharma plc industry is Biotechnology.
How many shares does ImmuPharma plc have in circulation?
The max supply of ImmuPharma plc shares is 4.16M.
What is ImmuPharma plc Price to Earnings Ratio (PE Ratio)?
ImmuPharma plc PE Ratio is now.
What was ImmuPharma plc earnings per share over the trailing 12 months (TTM)?
ImmuPharma plc EPS is -0.01 GBP over the trailing 12 months.
Which sector does the ImmuPharma plc company belong to?
The ImmuPharma plc sector is Healthcare.